Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao266042, China.
Department of Pharmacy, The First Affiliated Hospital of Suzhou University, Suzhou215000, China.
Mol Pharm. 2023 Feb 6;20(2):1189-1201. doi: 10.1021/acs.molpharmaceut.2c00881. Epub 2023 Jan 16.
Excessive acetaminophen (APAP) induces excess reactive oxygen species (ROS), leading to liver damage. Pterostilbene (PTE) has excellent antioxidant and anti-inflammatory activities, but poor solubility limits its biological activity. In this study, we prepared PTE-loaded Soluplus/poloxamer 188 mixed micelles (PTE-MMs), and the protective mechanism against APAP-induced liver injury was investigated. In vitro results showed that PTE-MMs protected HO-induced HepG2 cell proliferation inhibition, ROS accumulation, and mitochondrial membrane potential destruction. Immunofluorescence results indicated that PTE-MMs significantly inhibited HO-induced DNA damage and cGAS-STING pathway activation. For in vivo protection studies, PTE-MMs (25 and 50 mg/kg) were administered orally for 5 days, followed by APAP (300 mg/kg). The results showed that APAP significantly induced injury in liver histopathology as well as an increase in serum aspartate aminotransferase and alanine aminotransferase levels. Moreover, the above characteristics of APAP-induced acute liver injury were inhibited by PTE-MMs. In addition, APAP-induced changes in the activities of antioxidant enzymes such as SOD and GSH in liver tissue were also inhibited by PTE-MMs. Immunohistochemical results showed that PTE-MMs inhibited APAP-induced DNA damage and cGAS-STING pathway activation in liver tissues. For in vivo therapeutic effect study, mice were first given APAP (300 mg/kg), followed by oral administration of PTE-MMs (50 mg/kg) for 3 days. The results showed that PTE-MMs exhibited promising therapeutic effects on APAP-induced acute liver injury. In conclusion, our study shows that the Soluplus/poloxamer 188 MM system has the potential to enhance the biological activity of PTE in the protection and therapeutic of liver injury.
过量的对乙酰氨基酚(APAP)会诱导过多的活性氧(ROS),导致肝脏损伤。白藜芦醇(PTE)具有出色的抗氧化和抗炎活性,但溶解度差限制了其生物活性。在本研究中,我们制备了负载白藜芦醇的 Soluplus/泊洛沙姆 188 混合胶束(PTE-MMs),并研究了其对抗 APAP 诱导的肝损伤的保护机制。体外结果表明,PTE-MMs 可保护 HO 诱导的 HepG2 细胞增殖抑制、ROS 积累和线粒体膜电位破坏。免疫荧光结果表明,PTE-MMs 显著抑制了 HO 诱导的 DNA 损伤和 cGAS-STING 通路激活。对于体内保护研究,PTE-MMs(25 和 50mg/kg)经口给予 5 天,然后给予 APAP(300mg/kg)。结果表明,APAP 显著诱导了肝组织病理学损伤,并导致血清天冬氨酸转氨酶和丙氨酸转氨酶水平升高。此外,PTE-MMs 抑制了 APAP 诱导的急性肝损伤的上述特征。此外,PTE-MMs 还抑制了 APAP 诱导的肝组织中抗氧化酶如 SOD 和 GSH 活性的变化。免疫组化结果表明,PTE-MMs 抑制了肝组织中 APAP 诱导的 DNA 损伤和 cGAS-STING 通路激活。对于体内治疗效果研究,首先给予小鼠 APAP(300mg/kg),然后给予 PTE-MMs(50mg/kg)口服 3 天。结果表明,PTE-MMs 对 APAP 诱导的急性肝损伤具有良好的治疗效果。综上所述,我们的研究表明,Soluplus/泊洛沙姆 188 MM 系统有可能增强 PTE 在保护和治疗肝损伤方面的生物活性。